Genome-Based Diagnostics Demonstrating Clinical Utility in Oncology: Workshop Summary (2013) / Chapter Skim
Currently Skimming:
Appendix D: Registered Attendees
Appendix D: Registered Attendees
Pages 97-102
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 97... ...
Appendix D Registered Attendees Scott Allocco Mary Bordoni BioMarker Strategies Personalized Medicine Coalition Eric Assaraf Jennifer Bowman WRG American Clinical Laboratory Association Erin Balogh Institute of Medicine Pamela Bradley American Association for Cancer Robert Bast Research University of Texas MD Anderson Cancer Center Joel Brill Predictive Health, LLC Jessica Bayh Applied Policy Jeffrey Bush BD Al Benson III Robert H Lurie Comprehensive Khatereh Calleja Cancer Center, Northwestern AdvaMed University Allen Egon Cholakian Marian Birkeland IRDF Project Harvard/Columbia National Comprehensive Cancer Network Deborah Collyar Patient Advocates in Research 97
|
From page 98... ...
Leila Jamal Kennedy Krieger Institute Sarah Donovan Avalere Elaine Jeter Palmetto GBA Georgia Dunston Howard University Brett Johnson International Cancer Advocacy Tania Dutta Network Center for Medical Technology Policy Roger Klein University of South Florida School Christopher Earl of Medicine Innotrove, LLC Hon-Sum Ko Raith Erickson U.S. Food and Drug Complete Genomics Administration Lloyd Everson Nicole Kuderer The U.S.
|
From page 99... ...
Hannes Niedner Biotechnology Industry 5AM Solutions, Inc. Organization Danielle Pambianco Robert McCormack HillCo HEALTH Veridex, LLC David Parkinson Robert McDonough Nodality Aetna Scott Patterson Mary McGrane Amgen, Inc.
|
From page 100... ...
100 GENOME-BASED DIAGNOSTICS Kathryn Phillips Beverlyn Settles-Reaves University of California, San Howard University Francisco, Center for Translational and Policy Paul Sheives Research on Personalized Biotechnology Industry Medicine Organization Steve Phurrough Naoko Simonds Center for Medical Technology National Cancer Institute Policy Mary Lou Smith Margaret Piper Research Advocacy Network Technology Evaluation Center, Blue Cross Blue Shield Stuart Spector Association Center for Medical Technology Policy Bruce Quinn Foley Hoag, LLP Merianne Spencer Center for Medical Technology Samantha Roberts Policy Friends of Cancer Research Sylvia Trujillo Jeffrey Roche American Medical Association Centers for Medicare & Medicaid Services Sean Tunis Center for Medical Technology Greg Rossi Policy AstraZeneca UK Jessica Walrath Drew Saelens Friends of Cancer Research Applied Policy Corinne Warren Howard Scher Center for Medical Technology Memorial Sloan-Kettering Cancer Policy Center Richard Wenstrup Richard Schilsky Myriad Genetic Laboratories Comprehensive Cancer Center, University of Chicago Elizabeth West FasterCures Michele Schoonmaker Cepheid
|
From page 101... ...
APPENDIX D 101 Wendy Wifler Dara Wright Agendia, Inc. Affymetrix Marc Williams Amy Zettle Geisinger Health System Potomac Research Group
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.